Skip to main content

Table 1 Correlation of clinicopathological parameters and AIB1 mRNA expression in 185 breast cancer patients

From: Expression of AIB1 protein as a prognostic factor in breast cancer

  

AIB1 mRNA (n = 185)

 
  

low

high

p-value

Age

    
 

≤ 50

59

39

 
 

> 50

52

35

0.54

Histological type

   
 

IDC

107

66

 
 

non-IDC

4

8

0.05

Histological grade

   
 

well

41

15

 
 

moderate

47

41

 
 

severe

23

18

0.05

T stage

    
 

T1

69

29

 
 

T2

38

41

 
 

T3

4

4

0.01

Lymph node metastasis

   
 

negative

59

46

 
 

positive

51

28

0.16

Stage

    
 

T1

48

23

 
 

T2

41

37

 
 

T3

19

14

 
 

T4

3

0

0.13

ER

    
 

negative

30

27

 
 

positive

81

47

0.12

PR

    
 

negative

31

27

 
 

positive

80

47

0.14

HER2

    
 

negative

85

53

 
 

positive

26

21

2.28

AR

    
 

negative

19

5

 
 

positive

67

38

0.11

DAX-1

    
 

negative

25

7

 
 

positive

61

36

0.08

  1. AIB1: amplified in breast cancer I; IHC: immunohistochemistry; IDC: invasive ductal carcinoma; ER: estrogen receptor; PR: progesterone receptor; and AR: androgen receptor.